BIOMARKER:

Choline elevation

Choline elevation Choline elevation	Solid Tumor Solid Tumor	Choline elevation Choline elevation	Solid Tumor Solid Tumor	pembrolizumab Sensitive: C3 – Early Trials	pembrolizumab Sensitive: C3 – Early Trials
Choline elevation Choline elevation	Ovarian Serous Adenocarcinoma Ovarian Serous Adenocarcinoma	Choline elevation Choline elevation	Ovarian Serous Adenocarcinoma Ovarian Serous Adenocarcinoma	pembrolizumab Sensitive: C3 – Early Trials	pembrolizumab Sensitive: C3 – Early Trials
Choline elevation Choline elevation	Triple Negative Breast Cancer Triple Negative Breast Cancer	Choline elevation Choline elevation	Triple Negative Breast Cancer Triple Negative Breast Cancer	pembrolizumab Sensitive: C3 – Early Trials	pembrolizumab Sensitive: C3 – Early Trials
Choline elevation Choline elevation	Melanoma Melanoma	Choline elevation Choline elevation	Melanoma Melanoma	pembrolizumab Sensitive: C3 – Early Trials	pembrolizumab Sensitive: C3 – Early Trials
Choline elevation Choline elevation	Squamous Cell Carcinoma of Head and Neck SCCHN	Choline elevation Choline elevation	Squamous Cell Carcinoma of Head and Neck SCCHN	pembrolizumab Sensitive: C3 – Early Trials	pembrolizumab Sensitive: C3 – Early Trials

Associations